Taken together, we speculate that omentin levels were upregulated by CVD risk factors, such as aging, renal dysfunction, and chronic hyperglycemia, more potently than adiponectin to play a role against atherosclerosis in patients with T2D. This evidence concerns the gene ITLN1 and atherosclerosis.